Novartis

ARZERRA

Manufacturer:

Novartis

Arzerra HCPCS:

J9302

HCPCS Code Descriptor:

Injection, ofatumumab, 10 mg

Category:

J Code

Arzerra NDCs:

00078-0690-61, 00078-0669-13, 00078-0669-61

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00078-0690-61, 00078-0669-13, 00078-0669-61

About Arzerra:

ARZERRA is an Oncology drug manufactured by Novartis and administered via the Intravenous route of administration. The J Code: J9302 is aligned to the drug ARZERRA.

ACCESS PRICING AND MORE BY REGISTERING

J9302 Added Date:

January 1, 2011

J9302 Effective Date:

January 1, 2011

J9302 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Arzerra billing and coding information.
Arzerra patient assistance information can be found through Arzerra Oncology Access Program at the URL: https://www.us.arzerra.com/
ARZERRA prescribing information can be found at the link below:
Information regarding ARZERRA’s side effects can be found at MedlinePlus